Literature DB >> 2582970

Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.

T Fujikane1, T Shimizu, T Tsuji, S Ishida, Y Ohsaki, S Onodera.   

Abstract

The effects of cisplatin on the cell cycle and DNA synthesis of human lung adenocarcinoma cell line PC-9 were examined by flow cytometry. The cellular DNA content and the bromodeoxyuridine (BrdUrd) incorporation rate were measured simultaneously using a monoclonal anti-BrdUrd antibody. Following exposure to cisplatin (1.0 micrograms/ml) for 1 and 24 hr, the bivariate DNA/BrdUrd distributions revealed a delayed S-phase transit and an accumulation of cells in the G2M phase. The BrdUrd-linked green fluorescence intensity continued to decrease with the lapse of time. However, early- and mid-S-phase cells soon recovered DNA synthesis activity, and the former showed higher activity than the control cells. These findings suggested the vigorous DNA synthesis of cells in early S phase. However, for quantitative analysis of chemotherapeutic effects, some problems remained to be resolved regarding the condition for DNA denaturation and its alteration by the agents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2582970     DOI: 10.1002/cyto.990100617

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  7 in total

1.  Cytokinetic effects of cisplatin on diverse human head and neck carcinomas in vitro: dependence on the tumor sensitivity to cisplatin.

Authors:  M C Jäckel; R Tausch-Treml; P Köpf-Maier
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

3.  The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.

Authors:  M G Ormerod; R M Orr; C F O'Neill; T Chwalinski; J C Titley; L R Kelland; K R Harrap
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

4.  DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer.

Authors:  Catherine R Sears; Sean A Cooney; Helen Chin-Sinex; Marc S Mendonca; John J Turchi
Journal:  DNA Repair (Amst)       Date:  2016-03-03

5.  The role of apoptosis in cell killing by cisplatin: a flow cytometric study.

Authors:  M G Ormerod; R M Orr; J H Peacock
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

6.  Glutathione restores normal cell activation and cell cycle progression in cis-platinum treated human lymphocytes.

Authors:  M Kubbies; B Goller; B Schetters; I Bartosek; W Albert
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

7.  Chromatin folding and DNA replication inhibition mediated by a highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.

Authors:  Ryosuke Imai; Seiji Komeda; Mari Shimura; Sachiko Tamura; Satoshi Matsuyama; Kohei Nishimura; Ryan Rogge; Akihiro Matsunaga; Ichiro Hiratani; Hideaki Takata; Masako Uemura; Yutaka Iida; Yuko Yoshikawa; Jeffrey C Hansen; Kazuto Yamauchi; Masato T Kanemaki; Kazuhiro Maeshima
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.